Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01263249 · ClinicalTrials.gov registry record · Phase 4
Effects of Catheter Tip Location Relative to the Femoral Nerve on Sensory and Motor Function
A Phase 4 study of Continuous Femoral Nerve Blocks in Healthy Volunteers, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 4
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT01263249: Completed Phase 4 study of Continuous Femoral Nerve Blocks in Healthy Volunteers, sponsored by University of California, San Diego.
NCT01263249 is a Phase 4 study of Continuous Femoral Nerve Blocks in Healthy Volunteers that has completed, run by University of California, San Diego. The registered enrollment target is 19 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01263249, a Phase 4 study of Continuous Femoral Nerve Blocks in Healthy Volunteers, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine if the way local anesthetic, or numbing medication, is delivered through a tiny tube next to the nerves that go to the thigh affects the strength and sensation in the thigh.
Primary Outcome
The primary end point will be the quadriceps femoris maximum voluntary isometric contraction (MVIC) expressed as a percentage of the pre-ropivacaine MVIC: post / pre x 100; with the two sides of each subject compared with each other
Conditions Studied
Interventions
- PROCEDURE Catheter Anterior to the Femoral Nerve
- PROCEDURE Catheter Posterior to the Femoral Nerve
Study Locations (1)
California
- UCSD Medical Center, Hillcrest - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2010-01 |
| Est. Completion | 2011-06 |
| Phase | Phase 4 |
What the finished NCT01263249 record still lists
NCT01263249 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Continuous Femoral Nerve Blocks in Healthy Volunteers appearing as the primary indexed condition, and to 2 interventions - of which Catheter Anterior to the Femoral Nerve is the first listed.
NCT01263249 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01263249 about?
NCT01263249 is a clinical study titled "Effects of Catheter Tip Location Relative to the Femoral Nerve on Sensory and Motor Function". To determine if the way local anesthetic, or numbing medication, is delivered through a tiny tube next to the nerves that go to the thigh affects the strength and sensation in the thigh.
What is the current status of trial NCT01263249?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 19 participants. The study started on 2010-01. Estimated completion is 2011-06.
What conditions does trial NCT01263249 study?
This clinical trial studies the following conditions: Continuous Femoral Nerve Blocks in Healthy Volunteers.
What interventions are being tested in trial NCT01263249?
The interventions under investigation include: Catheter Anterior to the Femoral Nerve (PROCEDURE), Catheter Posterior to the Femoral Nerve (PROCEDURE).
Who is sponsoring clinical trial NCT01263249?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01263249 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01263249's enrollment target sits among peer trials
19 1834th of 2000 higher than 159 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia